Product Information

CETIRIZINE HCL 5 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0453 per EA under NDC 00378363501. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Dec 27, 2007.

CETIRIZINE HCL 5 MG TABLET

cetirizine hydrochloride
$0.0453per EA
OTC

Strength

5 mg/1

NDC

00378363501

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

CETIRIZINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA076677

FDA Approved

12/27/2007

On Market Since

12/27/2007

Pharmacological Classes

Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist

Price Statistics

The NADAC for CETIRIZINE HCL 5 MG TABLET has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 31.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0453 per EA
All-time high$0.0858 (Nov 13, 2019)
All-time low$0.0382 (Nov 20, 2024)
52-week high$0.0526
52-week low$0.0453
Median price$0.0556
Average price$0.0566
Largest weekly change+48.6% (May 22, 2019)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-4.8%

3M

-13.8%

6M

-5.5%

1Y

-4.9%

3Y

-17.9%

5Y

-15.5%

All

-31.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the cetirizine hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CETIRIZINE HCL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CETIRIZINE HCL 5 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.0453 per EA (NDC 00378363501), effective Nov 11, 2026.

How has the price of CETIRIZINE HCL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for CETIRIZINE HCL 5 MG TABLET has declined 31.4%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CETIRIZINE HCL 5 MG TABLET?

Since Nov 28, 2013, the NADAC for CETIRIZINE HCL 5 MG TABLET has ranged from a low of $0.0382 (Nov 20, 2024) to a high of $0.0858 (Nov 13, 2019), with a median of $0.0556 per EA.

Are there cheaper alternatives to CETIRIZINE HCL 5 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of CETIRIZINE HCL 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CETIRIZINE HCL 5 MG TABLET?

CETIRIZINE HCL 5 MG TABLET (NDC 00378363501) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.